USAA
CLDX icon

United Services Automobile Association’s Celldex Therapeutics CLDX Stock Holding History

United Services Automobile Association’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-969
Closed -$3K – 2263
2018
Q4 		$3K Hold
969
– – ﹤0.01% 2234
2018
Q3 		$7K Hold
969
– – ﹤0.01% 2306
2018
Q2 		$7K Hold
969
– – ﹤0.01% 2293
2018
Q1 		$34K Buy
+969
New +$37.5K ﹤0.01% 2240
2013
Q3 		– Sell
-2,700
Closed -$632K – 1229
2013
Q2 		$632K Buy
+2,700
New +$532K ﹤0.01% 1101

Other funds holding CLDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

United Services Automobile Association's CLDX Position: Q1 2019 in Review

United Services Automobile Association sold out of Celldex Therapeutics (CLDX) in Q1 2019, closing a stake of 969 shares — an estimated $3K sold.

United Services Automobile Association first reported a position in CLDX in Q2 2013 and held it in 5 quarters. The position peaked at $632K in Q2 2013. 53 funds tracked by Wall St. Rank hold CLDX as of Q1 2019.

  • United Services Automobile Association reported no remaining Celldex Therapeutics position as of Q1 2019 after selling out during the quarter.
  • United Services Automobile Association sold 969 Celldex Therapeutics shares in Q1 2019, an estimated $3K.
  • United Services Automobile Association first reported a position in Celldex Therapeutics in Q2 2013 and held it in 5 quarters.
  • United Services Automobile Association's Celldex Therapeutics position peaked at $632K in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q1 2019.

Based on United Services Automobile Association's 13F filing for Q1 2019, filed 13 May 2019.